Please login to the form below

Not currently logged in
Email:
Password:

Cadence Pharma

This page shows the latest Cadence Pharma news and features for those working in and with pharma, biotech and healthcare.

Mallinckrodt pays $1.2bn for Sucampo Pharma

Mallinckrodt pays $1.2bn for Sucampo Pharma

As 2017 drew to a close, Mallinckrodt signed a deal to buy Sucampo Pharma of the US - and its constipation drug Amitizia - for $1.2bn. ... bought Cadence Pharma for $1.3bn, Questcor for $6.5bn, immunotherapy outfit Therakos for $1.3bn and nuclear

Latest news

  • Ireland's Mallinckrodt buys US regenerative medicine firm Ireland's Mallinckrodt buys US regenerative medicine firm

    Stratatech’s StrataGraft in phase III testing for burns treatment. Ireland's Mallinckrodt Pharma has continued its acquisitive streak with a deal to buy Stratatech, a US firm developing a biologic ... Cadence Pharma and its injectable painkiller

  • Mallinckrodt cuts $5.6bn deal to buy Questcor Mallinckrodt cuts $5.6bn deal to buy Questcor

    Irish company continues move from medical imaging to pharma products. Mallinckrodt has dug deep into its pockets to buy Questcor Pharma and gain ownership of its fast-growing specialty drug HP ... It is the second transaction for Mallinckrodt in as many

  • Mallinckrodt offers $1.3bn for Cadence Pharma

    Deal would include injectable painkiller Ofirmev. Irish pharma company Mallinckrodt has agreed a $1.3bn deal to buy US biotech Cadence Pharmaceuticals and its fast-growing injectable painkiller Ofirmev. ... Mallinckrodt's offer comes shortly after

  • Cadence IV pain drug approved

    Cadence Pharmaceuticals has won US FDA approval for Ofirmev,  the first intravenous formulation of acetaminophen to be marketed in the US. ... Cadence Pharmaceuticals has won US Food and Drug Administration (FDA) approval for Ofirmev, which will become

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics